Skip to content

Study on the neural mechanism of cognitive dysfunction in heart-qi deficiency syndrome

Study on the neural mechanism of cognitive dysfunction in heart-qi deficiency syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2024000246
Enrollment
Unknown
Registered
2024-08-16
Start date
2024-07-16
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary heart disease

Interventions

Control group:none
Case group:none

Sponsors

Beijing Anding Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for case group: (1) Meet the diagnostic criteria of heart-qi deficiency syndrome; (2) Aged 18-65 years old, right-handed, junior high school education or above, simple Wechsler IQ test > 80, able to understand and cooperate with the questionnaire and examination involved in this study; (3) Meet the above diagnostic criteria for coronary heart disease, grade I to II heart function, and the condition is stable; (4) The total score of SCL-90 scale is 80, able to understand and cooperate with the questionnaire and examination involved in this study; (3) The total score of SCL-90 scale is < 160 points, and the number of positive items is < 43, and the score of any factor is not more than 2 points; Hamilton Anxiety Scale (HAMD) < 8 points, Hamilton Anxiety Scale (HAMA) < 7 points, Self-rating Anxiety Scale (SAS) < 50 points, Self-rating Depression Scale (SDS) < 50 points; (4) Voluntarily participate in clinical research and sign informed consent, and be able to understand and cooperate with this study.

Exclusion criteria

Exclusion criteria: Exclusion criteria for case groups: (1) There are contraindications to MRI scanning or poor blood pressure control, SBP=140mmHg, DBP=90mmHg; (2) Grade III to IV heart function, in the acute attack period, the condition is unstable; (3) Taking drugs other than those recommended by the guidelines for the treatment of heart failure and coronary heart disease; (4) Complicated with other cardiovascular diseases, such as atrial fibrillation, heart valvular disease, rheumatic heart disease, myocarditis, etc. (5) Those who have been diagnosed with mental diseases such as dementia, schizophrenia, depression and anxiety, have a history of major brain trauma, and have a history of major cerebrovascular accidents (cerebral hemorrhage, cerebral infarction); (6) In the past 2 weeks, there are serious infections, serious liver and kidney insufficiency, serious diseases of other systems except cardiovascular system, pregnant and lactating women, etc. Control group exclusion criteria: (1) Patients with contraindications for MRI examination; (2) Unable to understand and cooperate with the researcher.

Design outcomes

Primary

MeasureTime frame
electroencephalogram;

Secondary

MeasureTime frame
Stroop test;hs-TnT;NT-proBNP;Pittsburgh Sleep Quality Index;MR-proANP;Heart Qi deficiency syndrome accumulation table;Serum non-targeted metabolomics;hs-TnI;RBANS score;Heart rate variability;

Countries

China

Contacts

Public ContactHongxiao Jia

Beijing Anding Hospital, Capital Medical University

jhxlj@ccmu.edu.cn+86 136 6133 8687

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026